Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
PCAOB Audit completed Feb, Spin Off SOON!!!
Paul Riss
@PaulRiss
·
Feb 9
$PVSP has uploaded PCAOB audited financial statements. Thank you! Thank you! Thank you! Now they can work on #spinoff and creating value. Onward and upward! I think my $MHRE spinoff will happen first. It's a race.
https://twitter.com/PaulRiss
Schumer And Other Democrats Amplify Calls For Marijuana Reform Ahead Of 4/20
Which Congressman Says Should Be Celebrated ‘Every Day’
Published on April 17, 2024By Kyle Jaeger
Democratic senators, including Senate Majority Leader Chuck Schumer (D-NY), are “trying to recruit Republicans” to join them in the push for federal marijuana legalization, Senate Finance Committee Chairman Ron Wyden (D-OR) said at an event ahead of 4/20, which another lawmaker said is a holiday that should be celebrated “every day” this year as advocates work to get reform “across the finish line.”
At a press briefing organized by the Last Prisoner Project (LPP) on Wednesday, multiple congressional champions of cannabis legalization marked progress in the fight to end prohibition.
As Schumer, Wyden and Sen. Cory Booker (D-NJ) prepare to file a bill to federally legalize marijuana later this month, Wyden said the trio are “out right now trying to recruit Republicans to join in.”
Teen Marijuana Use Has Declined In Washington Since Legalization
“I want you to hear what my message is. I’m gonna say one word: Deschedule,” he said. “Descheduling ought to be a Republican dream… Sometimes I think they’re only for states’ rights if they think the state is right.”
Schumer, meanwhile, applauded advocates and discussed his work on legalization and cannabis banking reform in a pre-recorded video that was shared with Marijuana Moment ahead of a National Cannabis Policy Summit on Wednesday.
“My commitment to ending federal prohibition on cannabis remains as strong as ever,” he said. “As many of you know, cannabis reform is an issue I’ve cared about, and I’ve been working hard on, for years. And as many of you know, momentum is now in our favor.”
“Here in Congress, we’re making some good progress,” he said, pointing to the Senate Banking Committee passage of the Secure and Fair Enforcement Regulation (SAFER) Banking Act last September. Schumer also reiterated his interest in attaching a measure to incentivize state-level cannabis expungements to the legislation when it’s brought to the floor.
The majority leader also talked about his forthcoming Cannabis Administration and Opportunity Act (CAOA) to legalize marijuana.
“Cannabis legalization has proven successful at the state level. It’s high time that Congress catches up with the rest of the country,” Schumer said. “Of course, we know none of this is easy, especially in divided government. We need all of you to continue reaching out to members, especially Republican members, so we can make cannabis reform a reality.”
Back at the LPP event, Congressional Cannabis Caucus founding co-chair Rep. Earl Blumenauer (D-OR) touted his 51 years of work to reform state and federal marijuana laws. He also said it’s “appropriate” that advocates and lawmakers are celebrating 4/20 three days early because, “this year, we ought to be celebrating 4/20 every day.”
“Forces are aligned to be able to end this failed war on drugs and mobilize unprecedented support across the country,” he said. “And, frankly, the Biden administration has been doing a little realignment, which I welcome. But it’s time to not just realign but get it done.”
“President Biden, if I was interested in mobilizing young people—if I was interested in energizing them—this is a no-brainer,” Blumenauer said.
It is the whole reason for the Spin Off!
They have explained it a dozen times now, read the releases.
Paul is the Man!!!!!
Got to love this guy, he never quits and the Artizen spin off is going to set this gem FREE!!!
Just hope we can get the deal done soon, before the cannabis sector starts to run agin. With the much anticipated funding we should be able to acquire cannabis assets at Rock Bottom prices. Buying up some distressed Retail Locations in multi states would set to stock price on fire!!
"Company expects to file Qtrly report in several days"
The company was not able to complete its accounting for the period ended 02/29/2024 in sufficient time for
management to thoroughly review the report. The Company expects to file the report in several days
Riss Spin Off of HTSC to MHRE on FiRE!!
MHRE the California Garage Door Installer doing around $20M in sales with 100M shares outstanding is up 150% in past few months from .02 to .05.
PVSP spin off of Artizen will be structured the same, 100M shares outstanding, plus we keep all of our PVSP shares that will be to bring private company public, so we will own two new companies!!!
Keep and eye on this one.
https://ih.advfn.com/stock-market/USOTC/mesa-home-resources-pk-MHRE/chart
5 day Extension on Qtr Report has been Filed.
The Attorney Amended Letter may have caused delay or change in Qtr report, should be ready by end of week is my guess.
https://www.otcmarkets.com/stock/PVSP/overview
Florida Supreme Court approves ballot measure to legalize recreational marijuana
If the provision gets 60 percent in November, it will legalize recreational marijuana in the country’s third-most populous state.
Florida voters will have a chance to weigh in on recreational marijuana legalization this November. | John Minchillo/AP
By AREK SARKISSIAN
04/01/2024 05:43 PM EDT
TALLAHASSEE, Florida — The Florida Supreme Court will not block a ballot initiative that seeks to legalize recreational marijuana use for adults in this year’s general election, giving a major boost to the effort to open up pot use in the third-most populous state in the country.
With the green light from Florida’s conservative-leaning high court and more than 1 million signed and certified voter petitions in hand, Florida voters will have a chance to weigh in on an issue the state’s Republican-led Legislature has rejected for years.
The decision was in response to a request made by Florida Republican Attorney General Ashley Moody to reject the ballot language, arguing the measure fails to remind voters about a federal ban on marijuana.
Florida’s Supreme Court in a 5-2 ruling determined that the ballot language proposed by the Smart & Safe Florida committee to go before voters in November’s election fit the state’s single-subject rule for ballot initiatives.
Justice Jamie Grosshans wrote in the majority opinion that the ballot language was not too confusing for voters, and rejected an argument that the proposed amendment would require the Legislature to create new licenses to sell pot beyond the companies currently allowed to sell medical marijuana.
“We do not believe the summary would confuse a voter into thinking that the Legislature is required to authorize additional licenses,” the opinion states, later adding, “It clearly states that the amendment legalizes adult personal possession and use of marijuana as a matter of Florida law.”
Smart & Safe Florida’s campaign was funded by more than $39 million from Trulieve, which is the largest medical marijuana company in Florida. The proposed amendment, if approved by 60 percent of voters in November, would allow Trulieve and the 24 other companies licensed by the state to sell and grow pot for medical use to begin selling to anyone over the age of 21.
“We are thankful that the Court has correctly ruled the ballot initiative and summary language meets the standards for single subject and clarity. We look forward to supporting this campaign as it heads to the ballot this Fall,” Trulieve CEO Kim Rivers wrote in a statement, later adding that a coalition of companies has formed to aid in the campaign to November.
Trulieve operates 131 of the 618 medical marijuana dispensaries in Florida, and Moody used the Tallahassee-based company’s market position to argue that the ballot language was not written within the best interest of voters.
Lawyers from Moody’s office argued in briefs — filed before the court heard oral arguments in November — that the company was footing the bill for the initiative so it could lure consumers to willfully break federal law in the name of profit.
The justices all but dismissed Moody’s arguments during oral arguments. The same court had previously rejected two legalization initiatives from recent election years, handing down decisions that identified several mistakes. Lawyers for Smart & Safe Florida argued that the proposed language sought to address the mistakes that were cited by the court in the previous decisions, and Moody’s lawyers argued that the court should reconsider parts of the previous decisions.
In Monday’s opinion Grosshans wrote the amendment does not violate the single subject rule by impacting the state’s medical pot industry.
“Selling and possessing marijuana appear, for better or worse, directly connected, and we cannot say that an amendment addressing both components violates the single-subject requirement,” the opinion states.
Gov. Ron DeSantis in 2019 was hailed a champion by medical marijuana businesses and patients just weeks after he first took office, after he called on the state Legislature to repeal a ban on the sale of smokable marijuana known as flower.
DeSantis has since signed legislation that tightened the state’s controls on medical marijuana marketing to further prevent advertising that attracts children and implied that products were for recreational use. And his annual state budget recommendations to the Legislature have included millions in funding to expand testing, safety and enforcement efforts at the Office of Medical Marijuana Use.
DeSantis has, however, called recreational pot use a “real problem,” even lamenting the plant’s “stench.” While campaigning for president last year, DeSantis told reporters that marijuana has become more potent over the past two decades and warned that it could be laced with fentanyl.
“I think it’s a real, real problem, and I think it’s a lot different than stuff that people were using 30 or 40 years ago,” DeSantis said. “And I think when kids get on that, I think it causes a lot of problems.”
Florida already has the largest medical marijuana program in the country, with more than 871,000 patients registered with the state Department of Health.
More than 71 percent of voters legalized pot for medical use in 2016 after a successful ballot initiative backed heavily by high-profile Orlando lawyer and self-proclaimed “Pot Daddy” John Morgan, who contributed close to $7 million in cash.
LOL the Village Idiot speaks again, LOL
Dumbest post from you ever, it is a conspiracy, run for the hills, bla, bla, bla.
Congressional Lawmakers Push Attorney General To Issue ‘Overdue’ Marijuana Guidance, Saying Ongoing ‘Legal Limbo’ Is “Unacceptable’
Published on March 27, 2024By Kyle Jaeger
It is “unacceptable” that the Department of Justice has yet to reissue federal marijuana enforcement guidance to discourage interference in state cannabis programs, leaving Americans in a “legal limbo” despite promises to update the policy, two Democratic congressional lawmakers said in a new letter to the attorney general.
Writing to Attorney General Merrick Garland on Wednesday, Congressional Cannabis Caucus co-chairs Reps. Earl Blumenauer (D-OR) and Barbara Lee (D-CA) said the department should “correct this oversight and reissue a memo making clear DOJ’s limited resources will not be spent prosecuting those acting in accordance with state or Tribal law.”
It’s been over six years since then-Attorney General Jeff Sessions rescinded the previous Obama-era Cole and Wilkinson memos that generally directed prosecutors not to interfere with state and tribal marijuana laws, respectively. And making matters “especially concerning,” it’s been over a year since Garland signaled that updated guidance was forthcoming, they said.
CDC says teen pot use declined in Washington after legalization
“While we appreciate the historic steps the Biden-Harris Administration has taken to pardon federal simple possession marijuana offenses and begin the formal review of marijuana’s schedule under the Controlled Substances Act, it is unacceptable that more than half of Americans living in jurisdictions with legal marijuana markets are left in limbo without public guidance to prevent unjust prosecution of those complying with their state’s or Tribe’s regulations,” the lawmakers wrote.
“Law enforcement, state regulators, small businesses, patients, and everyday Americans are caught in the ambiguity of the federal-state gap, made worse by the delay in reissuing the Cole and Wilkinson Memoranda protections,” they said.
Blumenauer and Lee also noted that, for years, they’ve “urged DOJ to act on this commonsense protection,” and they’ve been “consistently disappointed in meetings with agency leadership and DOJ prosecutors on existing policies.”
“As congressional allies in the work to undue the harms of the misguided war on drugs, we request answers on the delays in reissuing these protections:
Given President Biden and Vice President Harris’ public position that no one should be incarcerated for marijuana possession, what steps is DOJ taking to ensure state- or Tribe-legal actions are not prosecuted?
What is the DOJ’s specific timeline for reissuing the Cole and Wilkinson Memoranda protections?”
“While Congress works to address the impacts of the federal-state gap on cannabis policy, the urgency of issuing public guidance addressing federal prosecution of those who comply with state and Tribe cannabis laws should inform DOJ’s actions,” the letter concludes. “We look forward to your response and to the long overdue reissuing of these critical, fiscally responsible, and common-sense protections.”
When Garland was asked about the issue during a Senate Judiciary Committee hearing last March, he said that it was “fair to expect” that the updated marijuana policy would be “very close to what was done in the Cole Memorandum.”
At an earlier hearing in June 2022, the attorney general said the Justice Department was still “examining a wide range of issues that relate to marijuana and its production, sale and use, and we intend to address these issues in the days ahead.”
While there’s still no formal guidance in place, the federal policy of non-interference in state cannabis programs has generally persisted over the recent administrations. But advocates want to see the memo reissued nonetheless for added protections.
In the meantime, the Drug Enforcement Administration (DEA) is working to complete its review into cannabis scheduling after the U.S. Department of Health and Human Services (HHS) recommended moving it from Schedule I to Schedule III of the Controlled Substances Act (CSA).
DEA Officials Discuss Marijuana Scheduling Timeline, Seeking To ‘Correct Misperceptions’ That Decisions Are Made In A ‘Shroud Of Secrecy’
Published on March 28, 2024
By Kyle Jaeger
A Drug Enforcement Administration (DEA) official says the agency wants to “correct misperceptions” that its drug scheduling review process is done in a “shroud of secrecy” as it works to reach a final decision on possibly reclassifying marijuana. He also said it sometimes takes up to six months for DEA to complete its analysis of health officials’ recommendations—which is just about how long it has now been since the agency began its current cannabis assessment.
In the latest episode of the agency’s “Prevention Profiles: Take Five” series, DEA Senior Prevention Program Manager Rich Lucey spoke with DEA pharmacologist Buki Ebeigbe about the scheduling process and specifically how it relates to the ongoing cannabis review—marking the first time that officials with the agency have discussed its current analysis of marijuana’s Schedule I status publicly in any depth.
“I just think it’s important for people to—again, going back to correcting misperceptions and really the issue of transparency and, by us even doing this podcast, just to help people understand the process,” Lucey said. “We don’t want it to necessarily feel as if it’s behind this shroud of secrecy, which I think then lends itself to this idea that it’s a whole arbitrary process.”
Transparency has been a key concern for advocates and lawmakers, with DEA declining to say anything publicly beyond confirming that they’ve received the recommendation from the U.S. Department of Health and Human Services (HHS) to move marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA) and are now carrying out their own review.
That process is “independent” of the HHS review, Lucey stressed.
That’s right,” Ebeigbe said. “It’s in its process. We’ve received [the HHS analysis], and we’re in the process of writing that recommendation” on cannabis scheduling to DEA Administrator Anne Milgram.
“Once that information is compiled and that document is written—that eight-factor document is written—it’s reviewed through our internal process,” she said, referring to the multi-step analysis the agency is completing on the effects of cannabis. “Ultimately, the administrator will make a decision on where to place it—whether to change it or whether to remove it or whatever.”
Lucey also commented on the complexity of drug scheduling reviews and what that means in terms of timing.
“Right now it’s a ‘wait and see.’ HHS has done their part, and now DEA is doing its part, which is that eight-factor analysis. And that can take anywhere from like three to six months sometimes,” he said. “I mean, it’s not like we’re going to be done in a week. It never happens that way.”
While Lucey was speaking generally about the drug scheduling review process, that timeline is notable. HHS delivered its Schedule III recommendation to DEA last August, meaning it’s been more than six months now that the drug agency has been conducting its own review. And there’s significant pressure to complete its work expeditiously.
Former governor launches Jesse Ventura Farms cannabis brand
Good time to jump in with both feet!!!
Matt Sepic Minneapolis
March 27, 2024 4:32 PM
Former Minnesota Governor Jess Ventura laughed and noted that "Jimi Hendrix is looking down on Minnesota" during remarks at the state capitol as current Governor Tim Walz signed a bill legalizing cannabis as of Aug. 1.
Ventura, who started the process by lighting a spark when he was governor, also said he was glad to have lived long enough to witness this day.
Judy Griesedieck for MPR News
Former Minnesota Gov. Jesse Ventura is launching his own brand of cannabis edibles.
Ventura is partnering with Columbia Heights-based Retro Bakery, which is producing hemp-derived THC edibles under the Jesse Ventura Farms brand.
Ventura, a longtime advocate of legalizing marijuana, testified in favor of the adult-use cannabis bill at the Legislature and was with Gov. Tim Walz when he signed it last year.
Ventura has said the drug helped his wife Terry get her seizures under control and alluded to that in his product launch video.
“Cannabis saved my family’s life, and now it’s time for me to return to the cannabis world,” he said in the video.
Retro Bakery said the Ventura-branded edibles will be available for pre-order on Monday, with a launch party at the Hook & Ladder in Minneapolis on April 20.
Why Marijuana Stocks Are Hopping Again on Tuesday
Rich Smith, The Motley Fool
Tue, Mar 26, 2024, 12:04 PM EDT2 min read
In This Article:
SNDL
+13.87%
Marijuana stocks are red hot Tuesday, as investors digest the latest cannabis news. And what news we've got! Last week, Vice President Kamala Harris voiced plans "to legalize marijuana" in the U.S. In just a few days, Germany will do just that, decriminalizing both marijuana possession and home cultivation of cannabis effective April 1.
Investors who pocketed gains yesterday are lining up to buy more on Tuesday. As of 10:40 a.m. ET, shares of marijuana stocks Cronos Group (NASDAQ: CRON), SNDL (NASDAQ: SNDL), and Canopy Growth (NASDAQ: CGC) are up 4.8%, 8.3%, and 11.8%, respectively.
Voters support cheaper marijuana
There's good reason for optimism. While U.S. federal marijuana legalization may or may not happen, support is building in Congress for legislation making sales at the state level -- where 24 states have fully legalized weed -- more profitable for the companies that sell it.
As cannabis news source Marijuana Moment reports, an American Bankers Association poll finds that 63% of voters polled support Congress passing a Secure and Fair Enforcement Regulation (SAFER) Banking Act to let cannabis companies secure loans and use other banking services. Leading senators such as Banking Committee Chairman Sherrod Brown and Senate Majority Leader Chuck Schumer already support the bill.
Legalizing bank services would lower the cost of doing business for companies that cultivate and sell marijuana, potentially making these businesses more profitable, allowing them to lower prices for consumers -- or both. As such, it's a logical next step for Congress to take, even prior to full-scale legalization.
Tick tock
All that said, Congress has been trying to pass "SAFER" for half a decade now, so far without success. While legalization is probably coming, in whole or in part, it remains to be seen which cannabis companies will survive to see it.
Analysts don't see Canopy Growth turning profitable before 2028 for example, or Cronos turning a profit... ever. SNDL, however, might earn a profit in 2025 -- and has enough cash to last eight more years at its current burn rate. When betting on marijuana legalization, don't forget to keep an eye on a company's cash.
Biden, at risk with young voters, is racing to shift marijuana policy
A Biden campaign aide said marijuana policy is one of a number of issues the campaign believes will motivate young people.
(Jose Luis Magana/AP)
BY NOAH BIERMAN
STAFF WRITER
MARCH 26, 2024 3 AM PT
WASHINGTON — Vice President Kamala Harris looked up from prepared remarks in the White House’s ornate Roosevelt Room this month to make sure the reporters in the room could hear her clearly: “Nobody should have to go to jail for smoking weed.”
Harris’ “marijuana reform roundtable” was a striking reminder of how the politics have shifted for a onetime prosecutor raised in the “Just Say No” era of zero-tolerance drug enforcement. As President Biden seeks badly needed support from young people, his administration is banking on cannabis policy as a potential draw.
Biden made similar comments to Harris’ in this month’s State of the Union address — though the 81-year-old president used the term “marijuana” instead of “weed.” The administration is highlighting its decision to grant clemency for pot possession as it races to have cannabis reclassified under the Controlled Substances Act before Biden faces voters in November.
“What’s good about this issue is it’s clean and it’s clear and it cuts through,” said Celinda Lake, one of Biden’s 2020 pollsters who also works for the Coalition for Cannabis Scheduling Reform, an industry group, along with Democratic organizations supporting Biden’s reelection. “And it’s hard to get voters’ attention in this cynical environment.”
The challenge is significant. Biden is viewed favorably by only 31% of people ages 18 through 29, much worse than he fares with other age groups, according to a recent Economist/YouGov poll. Though he leads former President Trump by 21 percentage points in that age group, he needs a high turnout to repeat his 2020 formula. Biden’s age probably has played a role in alienating a group that is both essential for Democrats and historically harder to galvanize than older voters, who more consistently show up at the polls.
The U.S. Department of Health and Human Services has delivered a recommendation to the Drug Enforcement Administration on marijuana policy, and Senate leaders hailed it Wednesday, Aug. 30, as a first step toward easing federal restrictions on the drug. (AP Photo/Hans Pennink, File)
WORLD & NATION
U.S. regulators might change how they classify marijuana. Here’s what that would mean
VENICE, CA - MARCH 20, 2024 - - Pedestrians walk past the now closed MedMen cannabis store on Abbot Kinney on March 20, 2024. A pair of signs on the front windows says that the store is closing temporarily. In the summer of 2018, cannabis retailer MedMen opened a boutique shop on Abbot Kinney Boulevard in Venice - "the coolest block in America," as the company hyped in a press release at the time. But, in the years that followed, the once rapidly expanding company began to unravel. Their stock plummeted to zero and recently they abruptly closed most of their California locations, including the one on Abbot Kinney, at least temporarily. (Genaro Molina/Los Angeles Times)
BUSINESS
“In the year 2024, it’s fair to expect more from a Democratic president,” said Matthew Schweich, executive director of the Marijuana Policy Project, a nonprofit trying to loosen laws at the local, state and federal levels.
Schweich said he worries about Trump returning to office but believes Biden has done the “absolute bare minimum,” missing a political opportunity to push for legalization in Congress and to advocate for the complete removal of marijuana from the controlled substances list, which Sen. Alex Padilla (D-Calif.) and 11 other Democratic senators urged in a January letter to the DEA.
Trump, whose administration threatened federal enforcement against localities and states that had legalized marijuana, is unlikely to attract support from legalization advocates.
Polling that Lake has done for the industry shows even the incremental step Biden is seeking could boost his approval by as much as 9 percentage points with younger voters in battleground states. But it’s hardly certain how that would play out.
A campaign aide, who would speak only on condition of anonymity, said marijuana policy is one of a number of issues the campaign believes will motivate young people — important but not as prominent as top-tier concerns including college affordability, reproductive rights, the economy, climate and healthcare.
The campaign cautions against treating young people as a monolith, noting that they care about a variety of issues and tend to see connections between them. Democrats, through a variety of methods including social media influencers and a newly launched campus outreach program, are trying to make the broader case to young people that Biden is fighting for equity and change while Trump is looking backward.
They note that young voters proved critical not only in Biden’s 2020 election but also in the 2022 midterm elections, when concerns over democracy and abortion rights helped the party perform better than expected.
Overall support for legalization is now at 70%, the highest recorded by Gallup, which began polling the question in 1969, when just 12% of Americans favored legalizing marijuana. The substance is legal in 24 states and Washington, D.C., for adults, and a total of 38 have made it legal for medical use, according to the National Organization for the Reform of Marijuana Laws, a legalization advocacy group.
The administration has pitched its marijuana agenda as part of its broader efforts to change other criminal sentencing laws and to improve job and business opportunities for people who have spent time in jail or prison.
Lake argues the two efforts combined could help Biden with Black men, another group where he has lost significant support since winning election in 2020.
Padilla said he still gets asked about marijuana regulations regularly, even though California was the first state to pass a medical-use law in 1996. “It resonates with a lot of people,” he said.
In practical terms, reclassifying marijuana changes little. Federal penalties would remain the same, though the Justice Department has for decades treated most marijuana crimes as low-priority prosecutions. It would remain illegal to transport pot across state lines, meaning access to banks and financial markets will remain a hurdle, even for companies operating in states that have legalized pot.
The biggest difference is that scientists and doctors could more easily study the drug for medical uses, something that is now practically banned. Such a change could open the door for greater acceptance. It also would lower tax burdens for the industry in states where it is legal, by allowing deductions for ordinary business expenses that are currently prohibited by the Internal Revenue Service.
Other potential changes are less certain. Banks and credit card issuers, for instance, would not immediately lift restrictions on marijuana transactions, though that could come if regulators in the Treasury Department decide to take up the issue, according to Shane Pennington, an attorney specializing in the Controlled Substances Act who has industry clients.
Health and Human Services Secretary Xavier Becerra speaks during an event announcing the launch of the Bureau of Global Health Security and Diplomacy at the State Department, Tuesday, Aug. 1, 2023, at the State Department in Washington. (AP Photo/Jacquelyn Martin)
SCIENCE & MEDICINE
Senators hail federal recommendation to ease restrictions on marijuana
Aug. 30, 2023
Biden proposed reviewing marijuana’s status in October 2022, a process that usually takes an average of more than nine years, Pennington said. The Department of Health and Human Services recommended Schedule III in August, the first step toward a change. A DEA spokesperson, in an email, said the agency would not discuss the issue while it is under review.
“It often takes a very long time, but we’re in unprecedented territory here” because the order came directly from the president, Pennington said.
Harris, in her roundtable discussion on marjuana reform, showed her impatience.
“I cannot emphasize enough that they need to get to it as quickly as possible, and we need to have a resolution based on their findings and their assessment,” she said.
The rushed nature of the process could expose the administration’s actions — which are almost certain to draw lawsuits — to further scrutiny.
Kevin A. Sabet, a former marijuana policy advisor in the Obama administration who heads an anti-legalization group, noted that Biden’s Health and Human Services Department released its preliminary recommendation at 4:20 p.m., slang for weed smoking time, underscoring the political nature of a normally button-down regulatory process. He argued that the decision was poorly crafted and could run afoul of U.S. treaty obligations.
But Sabet also agrees with advocates that Biden could have gone further.
“I think what the president wants to do is reap some of the benefits of the guy who’s embracing all this stuff without actually becoming in favor of legalization,” said Sabet, who heads the group Smart Approaches to Marijuana.
Florida bankers say passage of SAFE Act for cannabis clients is in sight
Banking & Financial Services
Medical marijuana is nearly a $2 billion industry in Florida, with over 800,000 licensed patients across the state.
RYLAND ZWEIFEL / EYEEM
Christina Georgacopoulos
By Christina Georgacopoulos – Reporter, Tampa Bay Business Journal
Mar 26, 2024
Updated Mar 26, 2024 7:30am EDT
“We need to be able to bank this population. It doesn’t matter whether you believe in [legalization] or not,” according to a Tampa banker who lobbied lawmakers to pass the SAFE Act while in D.C. last week.
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Schumer Circulates Petition For Marijuana Banking Bill As Pressure Builds For Vote
Published on March 22, 2024By Kyle Jaeger
Senate Majority Leader Chuck Schumer (D-NY) is asking people to show their support for a marijuana banking bill by signing a petition as he steps up his push for the legislation. In a new email about the effort, he also reiterated his support for comprehensive federal cannabis legalization.
With Congress positioned to pass a final package of appropriations legislation for the current fiscal year, lawmakers have been renewing their call to move the Secure and Fair Enforcement Regulation (SAFER) Banking Act. And in an email blast on Friday, Schumer again leaned into the issue.
“Can you imagine running a business without being able to deposit your money anywhere?” the email says. “That’s the reality for law-abiding marijuana businesses across the country.”
States That Legalized Marijuana See Massive Reduction in Tobacco Use
“In states where marijuana is legal, these businesses have extremely limited access to basic banking services like deposits or lines of credit. They’re forced to keep massive amounts of cash on hand—a danger for everyone involved,” it continues. “Banks are nervous to interact with legal marijuana businesses because marijuana remains illegal at the federal level.”
“I firmly believe that we should legalize marijuana. But while I continue pushing for legalization, these businesses need our immediate support,” Schumer said in the email promoting the online petition, which is a common list-building tactic for campaign fundraising. “Sign on to support the SAFER Banking Act and make sure marijuana business owners can access basic banking services.”
Completing the sign-on form then takes people to a brief questionnaire inquiring about their familiarity with the cannabis banking issue.
“Did you know about 90 percent of U.S. banks deny service to marijuana businesses?” one question asks.
“Did you know that if marijuana businesses do manage to get a bank account, they’re often charged sky-high service fees to cover the bank’s liability?” another prompt says.
“Senate Democrats are looking out for small business owners and fighting to end the unjust criminalization of marijuana. Will you help protect our Democratic Senate Majority to keep making progress on these issues?” it concludes, listing donation options.
The ball is currently in Schumer’s court. The Senate Banking Committee approved the bipartisan cannabis legislation last September, and now it’s a matter of scheduling it for floor action before it’s potentially sent over to the House, which has passed earlier versions of the proposal in some form seven times in recent sessions.
But at least in terms of messaging, lawmakers seem freshly optimistic about the bill’s prospects.
Schumer told Marijuana Moment earlier this month that the bill remains a “very high priority” for the Senate, and members are having “very productive” bicameral talks to reach a final agreement.
Senate Banking Committee Chairman Sherrod Brown (D-OH) also said on Thursday that passing the SAFER Banking Act off the floor is a “high priority.” However, he also recently said in a separate interview that advancing the legislation is complicated by current House dynamics.
House Majority Whip Tom Emmer (R-MN) separately said during an American Bankers Association (ABA) summit on Tuesday that he wants to see the SAFER Banking Act move.
He said that, “for whatever reason, the federal government has been slow” to act on the incremental reform that he supports even though he doesn’t identify as “a marijuana guy.”
One key factor that’s kept the bill from the Senate floor is disagreement over mostly non-cannabis provisions dealing with broader banking regulations, primarily those contained in Section 10 of the legislation.
Bicameral negotiations have been ongoing, however, and recent reporting suggests that a final deal could be just over the horizon.
The Democratic Senate sponsor of the SAFER Banking Act, Sen. Jeff Merkley (D-OR), told Marijuana Moment this month that the legislation is “gaining momentum” as lawmakers work to bring it to the floor and pass it “this year.”
The office of the Republican SAFER Banking prime sponsor, Sen. Steve Daines (R-MT), separately told Marijuana Moment that “conversations have been productive and Senator Daines is working to get the bill across the finish line.”
—
Marijuana Moment is tracking more than 1,400 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Germany legalises cannabis possession for personal use from April
German laws on cannabis use now among most liberal in Europe, but medical experts warn it ‘makes you stupid’.
22 Mar 2024
The German parliament has approved the partial legalisation of cannabis for personal use in a landmark vote that leaves the country with some of the most liberal laws on the substance in Europe.
Lawmakers in the Bundesrat, or the upper house, passed the long-debated bill on Friday, making it legal to obtain up to 25 grams (0.88 ounces) of the drug per day for personal use through regulated cannabis cultivation associations, as well as to have up to three plants at home, when the new rules come into effect on April 1.
The new law, which still prohibits possession and use of the drug for anyone under 18, will leave Germany with some of the most liberal cannabis laws in Europe.
Malta and Luxembourg legalised recreational use of the drug in 2021 and 2023, respectively. The Netherlands, known for its liberal cannabis laws, has been cracking down on sales to tourists and non-residents in recent years.
The cannabis law has been the subject of bitter wrangling within the coalition of Chancellor Olaf Scholz‘s Social Democrats, the Greens and the liberal Free Democratic Party (FDP). In their coalition agreement, the three parties had pledged to go further and allow cannabis to be sold in shops, a move slapped down by the European Union. They are now planning a second law to trial the drug’s sale in shops in certain regions.
In the run-up to the vote, Health Minister Karl Lauterbach, a member of the Social Democrats, called on members of parliament to back the controversial law, arguing that the country had seen a sharp rise in the number of young people using cannabis obtained on the black market.
Simone Borchardt of the opposition Christian Democratic Union (CDU) party, said the new law, fiercely opposed by medical associations, would only increase health risks for young people, accusing the three parties in Scholz’s coalition government of “making policy for their ideology and not for the country”.
The changes, which were passed by the Bundestag, or the lower house, last month, did not formally require Bundesrat approval. However members of the upper house could have called on a mediation committee and slowed down the process.
Cannabis
People meet for ‘World Stoner Day’, a demonstration for the immediate decriminalisation of cannabis, in Berlin, Germany, on April 20, 2023 [Nadja Wohlleben/Reuters]
Divisive
Proponents of the law, such as the German Cannabis Association, say black market cannabis can include sand, hairspray, talcum powder, spices or even glass and lead. Cannabis can also be contaminated with heroin or synthetic cannabinoids that are up to 100 times stronger than natural psychoactive cannabinoids, experts have said.
Steffen Geyer, director of Berlin’s Hemp Museum, expressed relief at the law, saying Germany had become “a little bit more free and tolerant”.
“This is the first step on the road to a rational and science-based drugs policy,” he said.
Health experts opposing the law warned that cannabis use among young people can affect the development of the central nervous system, leading to an increased risk of developing psychosis and schizophrenia. Sustained use has also been linked to respiratory diseases and testicular cancer.
“Chronic cannabis use makes you stupid, to put it bluntly, and can also cause psychosis,” Thomas Fischbach, president of a German federation of doctors for children and adolescents (BVKJ), told the Die Welt newspaper.
“Cannabis use among young people will increase because such substances are always passed on to younger people,” he said. “This could have serious consequences for young people’s physical and mental health.”
Advertisement
The German public is divided on the new law: according to a YouGov poll published on Friday, 47 percent are in favour of the plans and 42 percent are against.
FDA says marijuana has a legitimate medicinal purpose
As a Schedule 1 drug, marijuana is currently in the same category as some of the hardest drugs, like heroin and LSD.
The FDA released a report saying that marijuana does have a legitimate use for medical purposes and recommended the US Drug Enforcement Agency to change its classification from Schedule 1 to Schedule 3. “The definition of a schedule 1 drug says it has no health benefits to it, and, so, obviously, there’s been plenty of research that has documented the multitudes of ways that cannabis can be helpful,” said Dr. David Berger with Wholistic ReLeaf.
Marijuana
By: Anthony HillPosted at 5:43 AM, Mar 21, 2024 and last updated 7:13 PM, Mar 21, 2024
TAMPA, Fla. — The FDA released a report saying that marijuana does have a legitimate use for medical purposes and recommended the US Drug Enforcement Agency change its classification from Schedule 1 to Schedule 3.
“The definition of a schedule 1 drug says it has no health benefits to it, and, so, obviously, there’s been plenty of research that has documented the multitudes of ways that cannabis can be helpful,” said Dr. David Berger with Wholistic ReLeaf.
Recent Stories from abcactionnews.com
Though not all in the medical community agree, many people swear by the medicinal effects of marijuana to help treat symptoms of cancer, anxiety, PTSD and epilepsy.
“It’s no longer appropriate to say that there’s no medical benefit when there are hundreds if not thousands of medical studies that show the opposite,” explained Dr. Berger.
As a Schedule 1 drug, marijuana is in the same category as some of the hardest drugs like heroin and LSD, which means it’s classified as being more dangerous than fentanyl and methamphetamine.
“What happens after this is the federal government has more decisions to make as to what they’re going to do next,” said Dr. Berger.
CDEL MM did the same today, making market.
CDEL bought the 9m dumped at open today at BID of .0003, and then placed the 9M on the ASK for .0004, looking to make the spread profit.
Easy $900 for one trade.
That is what MM do, they make a market
They BUY at the Bid and SELL on the ASK, that is what you are seeing.
Very, very little actual trading going on.
+ 65% in One Hour, LOL. Now 80% Gain!!!
These Cannabis stocks can gain 100% in 2 minutes while it took 2 years to lose 80%!!!
Last run for PVSP was over 1400% gain!!
Stock today is worth .02 just on current share structure!!
It will Run Big Time just a matter of when, and you better have bought your ticket and not chase it!!!
Don't you just love a nice SHORT Squeeze, +46% LOL
Cannabis sector is ready for HUGE rebound. Schumer says expects Safe Banking approval by election!
MindMed’s stock jumps 24% after FDA grants breakthrough designation
MindMed’s stock jumps 24% after FDA grants breakthrough designation to LSD therapy for a form of anxiety
By Ciara LinnaneFollow
Biotech also issues new shares and reports positive data from Phase 2b trial
Mind Medicine Inc.’s stock jumped 24% early Thursday, after the biotech company said the Food and Drug Administration has granted breakthrough designation for its MM120 LSD-based treatment for generalized anxiety disorder.
Published: March 7, 2024 at 8:26 a.m. ET
Board of Dopes, LOL
Seriously Mr. Free shares that has to be your dumbest post ever!
Do you even do any research, any at all? I didn't think so, just blab, blab, blab.
The Cannabis wholesale market has seen a price drop of over 50% in the past few years, and you are not happy that Artizen has been able to maintain revenues by cutting expenses, improving operations etc, etc.
They have done a great job in managing the business in difficult times of oversupply and declining prices.
Key Highlights
Gross Profit for the year ending November 30, 2023 totaled $4,890,763 on $15.8 million in revenues, compared to gross profits of $2,724,601 during the same period in 2022.
Gross Margins improved from 17% to 31%, a 182% increase. The improved gross margin reflects increases in production yields and gains in production efficiencies.
Revenues of $15.8 million equal 2022 revenues, achieved in a market that continues to battle over supply and price compression.
Operating Loss for the year ending November 30, 2023 totaled ($460,037), compared to an operating loss of $2,422,916 during the same period in 2022.
Cashflow for the year ending November 30, 2023 totaled $409,507, compared to negative cashflow of ($798,033) during the same period in 2022.
Income Tax liabilities increased due to a materially improved Gross Profit. Under 280e tax treatment, the Company is being taxed on Gross Profit as compared to non-cannabis businesses being taxed on Net Income.
“We continued to increase yields and margins in a market that is still challenged by oversupply and price compression.” said German Burtscher, Pervasip’s President and Chief Executive Officer.
Debt Holders $15m, becomes Equity Holders!!!
Debt Holders are getting 15% of Artizen spin off and will become Equity Holders. That 15% is coming from Founders 85%, PVSP holder keep their entire 15%, no dilution.
Gross Profit $4,890,763 on $15.8 million in revenues
Reports 2023 Revenues of $15.8 Million from Artizen Corporation
SEATTLE, WA, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Pervasip Corp. (OTCPK: PVSP) (“Pervasip” or the “Company”), a developer of companies and technologies in high value emerging markets, today announced the filing of its unaudited financial statements for its fiscal years ended November 30, 2023.
Key Highlights
Gross Profit for the year ending November 30, 2023 totaled $4,890,763 on $15.8 million in revenues, compared to gross profits of $2,724,601 during the same period in 2022.
Gross Margins improved from 17% to 31%, a 182% increase. The improved gross margin reflects increases in production yields and gains in production efficiencies.
Revenues of $15.8 million equal 2022 revenues, achieved in a market that continues to battle over supply and price compression.
Operating Loss for the year ending November 30, 2023 totaled ($460,037), compared to an operating loss of $2,422,916 during the same period in 2022.
Cashflow for the year ending November 30, 2023 totaled $409,507, compared to negative cashflow of ($798,033) during the same period in 2022.
Income Tax liabilities increased due to a materially improved Gross Profit. Under 280e tax treatment, the Company is being taxed on Gross Profit as compared to non-cannabis businesses being taxed on Net Income.
“We continued to increase yields and margins in a market that is still challenged by oversupply and price compression.” said German Burtscher, Pervasip’s President and Chief Executive Officer.
Since the successful completion of its comprehensive financial audit for fiscal years ending November 30, 2022 and 2021, the Company has entered into debt restructuring efforts for one of its operating companies in preparation for the spin out of its cannabis assets and efforts to further reduce its real estate footprint in Washington State.
Audited 2023 financials are expected to be completed by end of April 2024.
Great article PA Governor push to Legalize Cannabis
Pennsylvania Governor Says Lawmakers ‘Don’t Even Have A Choice’ But To Legalize Marijuana As Other States Move Ahead
Published 19 hours ago on February 12, 2024By Kyle Jaeger
Pennsylvania’s governor says he thinks officials in the state “don’t even have a choice anymore” on legalizing marijuana, and he feels there’s bipartisan momentum that lawmakers should leverage to get the job done.
With neighboring states such as Ohio enacting legalization in recent years, Pennsylvania Gov. Josh Shapiro (D) said last week that “this really comes down to an issue now of competitiveness,” as the state is currently “losing out on 250 million bucks a year in revenue that could go to anything from economic development, education, you name it.”
“The reality is, as long as we have safeguards in place to make sure our children aren’t getting their hands on it—it’s just like, we don’t want our kids out drinking, right?” he said. “And a lot of that is going to be a burden on parents and schools and others to make sure we educate on that. Then I think this is something we’ve got to compete on.”
States That Legalized Marijuana See Massive Reduction in Tobacco Use
“I actually think we don’t even have a choice anymore given the way in which this is moving so quickly across our region and across the country,” Shapiro told WILK News Radio, adding that he’s personally “evolved on” the issue and wants a legal cannabis market “focused on lifting up Pennsylvania businesses in the process—not these big national conglomerates—and we’re empowering people in local communities to it that I think some good can come from it.”
The governor made the comments days after unveiling a budget proposal that calls for marijuana legalization to be enacted this year, with sales beginning as early as next January.
Cannabis reform has stalled in the Pennsylvania legislature over recent sessions, but Shapiro said he sees a path forward this year.
“You’ve got some of the legislature who just—you know, it cracks me up they’re like kneejerk against everything I’m for, but that’s like their politics,” he said. “But I think what you’re beginning to see is, from the thoughtful folks out there, some bipartisan support emerged and you’ve got Democrats and Republicans sponsoring bills to legalize it.”
“It’s obviously wildly popular across the country and certainly in polling regionally and in the states. So if someone’s going to be against it, I think they’re going to have to justify that to their constituents as well,” he said. “There does seem to be an emerging bipartisan consensus that we’ve got to compete on this issue, and we’ll see if we can get it done. We’re going to work hard.”
In a separate interview with KDKA News Radio that the governor’s office also promoted last week, Shapiro noted that his office estimates that Pennsylvania could bring in $250 million in tax revenue annually from cannabis sales.
“The reality is we are leaving all that money on the table. We are falling behind other states,” he said. “I think it’s another story of us not being as competitive as we need to be, and I think its time has come.”
“It’s time to shut down the black market. It’s time to take the strain off of cops. It’s time to be competitive. And this is a way to do that,” the governor said. “We can’t let Ohio and the other states around us keep eating our lunch on this or any other issue. As I’ve said many times, I’m competitive as hell and this is one of those areas. We’ve got to compete it.”
A staffer in Shapiro’s office similarly remarked on the need to legalize marijuana after Ohio voters approved the reform at the ballot last November.
Also last week, Pennsylvania lawmakers convened another hearing on marijuana legalization issues—focusing on the industry perspective, with multiple stakeholders from cannabis growing, dispensing and testing businesses, as well as clinical registrants, testifying.
“From the outset, my personal goals for adult-use has been to put health and safety of our constituents first and to allow for equitable and meaningful opportunities, particularly for those harmed by the war on drugs,” Rep. Dan Frankel (D), chair of the full Health Committee who previously sponsored cannabis legalization legislation, said at the beginning of last week’s hearing
NITE on BID for 38 Million, 10k on ASK, LOL
MM are trying to get more cheap shares, BID is stacking with 103 Million, ASK only 5 Million
CDEL on BID for 32 Million, on ASK 5 Million
GTSM on BID for 18 Million, on ASK 1 Million
ETRF on BID for 16 Million, on ASK 85K
INTL on BID for 25 Million, on ASK 10k
Jettison over 80% of Debt, with No Dilution!!!!
This restructuring demonstrates Pervasip's commitment to strengthening its financial position and streamlining
operations. It plans to jettison over 80% of its debt by engineering a spinoff into a new cannabis-focused entity,
without diluting the public shareholders. The current management team is giving up ownership interest in the
spinout pubco to create more value for the public shareholder and reduce debt-to-equity ratios, thereby
fortifying its balance sheet and improving overall financial health.
Your Word, LOL, LOL, LOL, LOL, LOL
Now that was funny, needed a good laugh!!!
You can't Buy on Record Date and get Artizen shares!
Don't think you can just wait until the Record Date to Buy. If you do you will not receive the Artizen Shares distribution.
To be eligible for the Artizen Distribution, you will need to buy the stocks before the ex-dividend date, which generally is two days before the record date.
Also, remember it takes T+2 days to get registered and updated, so keep those as buffer days and do not just wait for the last date to buy the stocks.
$PVSP In answer to those pesky RS rumors! NO!
Series K shareholders have agreed to a restructuring and spin-off and Pervasip has announced the plans in its March 2, 2023 press release.
1. Spin out all cannabis assets into a standalone entity and uplist to OTCQB, preserve 15% of all stock for float (= current fully diluted %), AND all debt dilution NOT carried by current float but converted K shareholders! Thank you!
2. The remaining Pervasip as a second standalone will see a REDUCTION of KShares from 85% to 20%. NO RS!
No Reverse Split, LOL Dopes
Pervasip Corp
@PervasipC
·
16s
$PVSP In answer to those pesky RS rumors! NO!
Series K shareholders have agreed to a restructuring and spin-off and Pervasip has announced the plans in its March 2, 2023 press release.
1. Spin out all cannabis assets into a standalone entity and uplist to OTCQB, preserve 15% of…
Show more
What an ignorant dope, LOL
Sad really, big mouth idiot, lazy cyber bully, LOL
What Is a Reverse Stock Split?
A reverse stock split is a measure taken by a public company to reduce its number of outstanding shares in the market. Existing shares are consolidated into fewer shares. This results in a higher stock price for the stock shares but has no immediate effect on the total value of the stock to the investor or the market capitalization of the stock.
For example, if a stock is trading at 50 cents on the market, and the company declares a two-for-one reverse stock split, an investor who owned 100 shares worth 50 cents would own 50 shares worth $1 each.
KEY TAKEAWAYS
A company performs a reverse stock split to boost its stock price by decreasing the number of shares outstanding.
A reverse stock split has no immediate effect on the company's value, as its market capitalization remains the same after it’s executed. However, it often leads to a drop in the stock's market price as investors see it as a sign of financial weakness.
This path is usually pursued to prevent a stock from being delisted or to improve a company's image and visibility.
You will never have enough information, only more questions, LOL
If you are that worried about investing, why in the world are you playing with micro penny pink stocks?
Seriously what gives with you?
A reverse split is nothing more than someone giving you a hundred dollar bill for 100 one dollar bills.
The problem markets have with some companies that do R/S is why they are doing R/S. Usually they are all ready very weak, with declining revenues and profits, along with share price, and are doing the r/s to meet listing requirements to stay on a particular exchange.
Doing R/S to uplist on the OTC while revenue and probits are increasing along with share price is really a non issue except for the few dumb shorties that cannot tell the difference.
PVSP will NEVER reverse split, Reverse Merger Yes
PVSP shareholders are going to own 80% of the company after the Spin Off, vs the current 15%.
The 20% remainder will be held by the original Artizen founders, and they will use those for any future CD's that maybe needed.
Great deal for current PVSP shareholders, the Artizen founders are being more than fair to PVSP shareholders.
Remember they have spent 10's of Millions building Artizen business since 2013, when it was a private company.
IMO, PVSP will do a reverse merger once again with a profitable private company that wants to go public and there are many out there.
It is so funny watching those clowns chase every tic, LOL
Seriously, who cares if it drifts around, it is what it is short term. They act like investors are going to jump off a bridge if it tics lower.
If it tics back lower, just means investors will continue loading the boat for a few more weeks or months, but I don't think so.
2024 is going to be a BIG, BIG year for shareholders!!!
Very Healthy Consolidation going on now.
We have to build a new higher base and the only way to do that is to let the daytrader get off the train and replace them will longer term investory that don't need sell before the weekend, LOL
Beer money trading.
It took 2 yrs from 1 cent to .0002, will take a few months to get back up!
MM are using algorithms to trade, and getting 75% and holding it a day is not likely, and that is their job really so let it trade up and down, the only thing that matters is that we get to our destination, not how many stop we hit along the way.
Future is what I am look for, 1 to 2 years out will look very different.
"PVSP shareholders will own 85% vs the current 15%"
“While Pervasip common shareholders of record at the spin-out closing date will collectively receive 15% of Artizen’s common shares in addition to keeping their existing Pervasip common shares, Pervasip’s Series K preferred stock will be restructured immediately after completing the Artizen spin-out to reduce the applicable conversion rights from 85% of Pervasip’s fully diluted issued and outstanding stock to 20%.
Importantly, that 20% then will also absorb the full impact of all other Pervasip convertible equity and debt securities. As a result, in addition to receiving 15% of Artizen in the spin-out transaction, Pervasip’s common shareholders will collectively hold 80% of Pervasip’s fully diluted shares immediately after the spin-out transaction instead of the current 15%.”